Graham R. Foster - Concepedia

Author

Graham R. Foster

Also Known As

Charles Gore, Christiansen Christmann, David Ramanaden, Foster, Graham, Foster, Graham R., Foster, GR, G Cooke, G FOSTER, G Foster, G R FOSTER

691

Publications

27.7K

Citations

H-Index

213

Concepts

All Affiliations

Queen Mary University of London University College London Goethe University Frankfurt King's College Hospital Imperial College London

About

Graham R. Foster is an author at Queen Mary University of London specializing in medicine, hepatitis, and viral hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	48	109	8.6K
2	Health Sciences	10	11	975
3	Engineering	5	5	223
4	Natural Sciences	2	2	46
5	Nursing	1	1	23

Graham R. Foster

230

Publications

21.6K

Citations

H-Index

Page 1

	Year	Citations
Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection Nezam H. Afdhal, Stefan Zeuzem, Paul Y. Kwo, New England Journal of Medicine	2014	1.7K
Telaprevir for Retreatment of HCV Infection Stefan Zeuzem, Pietro Andreoné, Stanislas Pol, New England Journal of Medicine	2011	1.5K
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection Graham R. Foster, Nezam H. Afdhal, Stuart K. Roberts, New England Journal of Medicine	2015	845
Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis Graham R. Foster, Robert Goldin, Howard C. Thomas Hepatology Quality Of LifeChronic Hepatitis CCirrhosisAutoimmune Liver DiseaseViral Hepatitis	1998	563
MAIT cells are activated during human viral infections Bonnie van Wilgenburg, Iris Scherwitzl, Edward Hutchinson, Nature Communications	2016	509
Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals Natasha K. Martin, Peter Vickerman, Jason Grebely, Hepatology	2013	499
Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis Graham R. Foster, William L. Irving, Michelle Cheung, Journal of Hepatology HepatologyHepatitis CViral HepatitisLiver PhysiologyImmunology	2016	490
Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease Daniel Forton, Howard C. Thomas, Christine Murphy, Hepatology	2002	446
Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial Ira M. Jacobson, Gregory J. Dore, Graham R. Foster, The Lancet HepatologyHepatitis CViral HepatitisAntiviral Drug DevelopmentAntiviral Therapy	2014	434
Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection Stefan Zeuzem, Graham R. Foster, Stanley Wang, New England Journal of Medicine	2018	426

Page 1